Patients treated with oxaliplatin are at risk for thrombocytopenia caused by multiple drug-dependent antibodies.

TitlePatients treated with oxaliplatin are at risk for thrombocytopenia caused by multiple drug-dependent antibodies.
Publication TypeJournal Article
Year of Publication2018
AuthorsCurtis BR, Hsu Y-MS, Podoltsev N, Lacy J, Curtis S, Samuel MS, Zutavern K, DeSimone RA, Bougie DW, Aster RH
JournalBlood
Volume131
Issue13
Pagination1486-1489
Date Published2018 03 29
ISSN1528-0020
KeywordsAged, Autoantibodies, Colonic Neoplasms, Female, Humans, Male, Middle Aged, Oxaliplatin, Purpura, Thrombocytopenic, Idiopathic, Stomach Neoplasms
DOI10.1182/blood-2017-10-812461
Alternate JournalBlood
PubMed ID29439950
PubMed Central IDPMC5877442
Grant ListR01 HL013629 / HL / NHLBI NIH HHS / United States
R37 HL013629 / HL / NHLBI NIH HHS / United States
R56 HL013629 / HL / NHLBI NIH HHS / United States
UL1 TR001863 / TR / NCATS NIH HHS / United States
Related Faculty: 
Robert DeSimone, M.D.

Pathology & Laboratory Medicine 1300 York Avenue New York, NY 10065 Phone: (212) 746-6464
Surgical Pathology: (212) 746-2700